Alcon Inc(ALC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | 50.63 | EPS (ttm) | 1.3 | Insider Own | 0.11% | Shs Outstand | 483.4M | Perf Week | -8.39% |
| Market Cap | 31.83B | Forward P/E | 16.64 | EPS next Y | 13.61% | Insider Trans | - | Shs Float | 481.6M | Perf Month | -10.26% |
| Enterprise Value | 35.68B | PEG | 1.23 | EPS next Q | 0.88 | Inst Own | 53.37% | Short Float | 3.02% | Perf Quarter | -0.72% |
| Income | 0.64B | P/S | 2.93 | EPS this Y | 13.75% | Inst Trans | 0.32% | Short Ratio | 7.64 | Perf Half Y | -15.89% |
| Sales | 10.86B | P/B | 1.48 | EPS next 5Y | 13.53% | ROA | 2.06% | Short Interest | 14.57M | Perf YTD | -16.22% |
| Book/sh | 44.67 | P/C | 21.86 | EPS past 3/5Y | 42.85% - | ROE | 2.94% | 52W High | -24.66% ($87.64) | Perf Year | -17.13% |
| Cash/sh | 3.02 | P/FCF | 18.29 | Sales past 3/5Y | 6.06% 8.77% | ROIC | 2.45% | 52W Low | 6.78% ($61.83) | Perf 3Y | -20.67% |
| Dividend Est. | $0.36 (0.55%) | EV/EBITDA | 14.47 | EPS Y/Y TTM | -39.47% | Gross Margin | 56.85% | Volatility(W/M) | 1.66% 1.54% | Perf 5Y | -21.21% |
| Dividend TTM | 0.36 | EV/Sales | 3.28 | Sales Y/Y TTM | 8.34% | Oper. Margin | 10.93% | ATR (14) | 1.48 | Perf 10Y | - |
| Dividend Ex-Date | 2026/5/6 | Quick Ratio | 1.3 | EPS Q/Q | -100% | Profit Margin | 5.92% | RSI (14) | 28.83 | Recom | 1.78 |
| Dividend Gr. 3/5Y | 15.62% 25.32% | Current Ratio | 2.09 | Sales Q/Q | 8.74% | SMA20 | -7.9% ($71.69) | Beta | 0.88 | Target Price | $87.35 |
| Payout | 16.97% | Debt/Eq | 0.25 | Earnings | 2026/8/10 | SMA50 | -6.18% ($70.38) | Rel Volume | 1.02 | Prev Close | $66.55 |
| Employees | 25942 | LT Debt/Eq | 0.22 | EPS/Sales Surpr. | 11.36% 0.72% | SMA200 | -11.12% ($74.29) | Avg Volume(3M) | 1.91M | Price | $66.03 |
| IPO | 2019/4/9 | Option/Short | Yes/Yes | Trades | 19639 | Volume | 1,942,177 | Change | -0.78% |
Company
ALC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
👁️ A leading global eye care company that supplies ophthalmic surgical equipment and supplies, contact lenses, and ophthalmic pharmaceuticals. Founded in 1945 in Texas, USA, it is currently headquartered in Geneva, Switzerland, and is a global leader in ophthalmic solutions that was spun off from Novartis in 2019 to return to standalone public listing.
Over the past 1 year, on the lower side
25% below its 1-year high.
ALC makes money exceptionally well
10.93% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.8% this year.
Tap to view numbers
The stock looks undervalued
Trading at 50.6 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -20.7% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.55% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 53.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
EQTY 0.03%
AGNG 0.02%
BKCI 0.02%
FLSW 0.02%
RUNN 0.02%It ranks #4 in the industry
Based on market cap of $32B.
ALC $32B PER 50.6
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
실적분석 · 8/10 Alcon ($ALC) Q2 2026 Earnings Analysis — Core EPS Beats Expectations, Full-Year Outlook Raised 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is ALC?
ALC belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ALC?
The market cap of ALC is approximately $31.8B, ranking 451 within its sector.
Does ALC pay dividends?
ALC has a dividend yield of approximately 0.55%, with an annual dividend of $0.36.
What is the P/E ratio of ALC?
ALC has a P/E ratio of approximately 50.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALC?
ALC has recorded a 52-week high of $87.64 and a low of $61.83.
